Stay updated on Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.

Latest updates to the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH banner announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” in agency content.SummaryDifference0.3%

- Check7 days agoChange DetectedThe footer's site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check35 days agoChange DetectedThe page's release version was updated from v3.6.6 to v3.7.0, indicating an underlying platform update for the Record History page. This change does not modify the recorded study history data.SummaryDifference0.1%

- Check42 days agoChange DetectedThe record history now shows the study status updated to Completed and the recruitment status set to No longer looking for participants, indicating enrollment has ended.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision tag updated from v3.6.5 to v3.6.6 on the page, signaling a new site version is in use. This is a metadata update and does not modify the study data or visible record content.SummaryDifference0.0%

Stay in the know with updates to Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapirolizumab Pegol in Lupus: Efficacy and Safety Clinical Trial page.